SEC
SlamSEC
SearchBrowseEarnings

Organogenesis Holdings Inc.

Nasdaq:ORGO
Pharmaceutical Preparations·CANTON, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Governanceproxy statements · beneficial ownership

Proxy Statements

17 shown
FiledFormDescription
5/12/25DEF 14ADEF 14A→
4/29/25PRE 14APRE 14A→
4/29/24DEF 14ADEF 14A→
5/1/23DEF 14ADEF 14A→
5/10/22DEF 14ADEF 14A→
4/29/22PRE 14APRE 14A→
↓

Ownership Filings

40 shown
FiledFormDescription
3/3/264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES→
3/3/264/AAMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES→
3/3/264/AAMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES→
3/3/264/AAMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES→
3/3/264/AAMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES→
3/3/264/AAMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES→
↓

Organogenesis is the phase of embryonic development that starts at the end of gastrulation and continues until birth. During organogenesis, the three germ layers formed from gastrulation form the tissues and internal organs of the organism.

CEO
Gillheeney Gary S.
CFO
Francisco David